Interbat was first founded in 1948 by the late Mr. Djoko Sukamto as the sole Indonesian distributor for European pharmaceuticals such as Crinos S.p.A, Zambon, Gentili S.p.A, and Cipan Pharmaceutical.

In 1959, Interbat obtained its own production permit and has since established ourselves as an independent pharmaceutical manufacturer.
In 1971, when Indonesia's Ministry of Public Health regulated a Good Manufacture Practices (GMP) standard for the first time, we immediately received recognition for using manucturing facilities that all conformed to this newly-formed standard.

On May of 1977, we moved all of our production activities to a new two-hectare factory complex in Sidoarjo, situated 15 km from Surabaya, East Java. Since then, Interbat had undergone three factory expansions and major upgrades to its manufacturing facilities, production equipments, quality control laboratories and other regulated facilities, all the while receiving 31 GMP certificates according to WHO standards. This focus for improvement ensures that our products continue to meet strict local and international standards.

Currently, Interbat produces more than 270 different products in various dosages and forms and is regarded as one of the top pharmaceutical manufacturers in the nation. In the past decade, in fact, we have been constantly ranked within the top five Indonesian pharmaceutical manufacturers. With a focus on improvement being the norm in Interbat, we are positive that our future will prove to be even more astounding than our past history.

In seeking to establish strategic alliances in both export and import sectors, we realize the need to become a cutting edge choice for our potential partners. As such, Interbat is focused on constantly improving both our product offerings and the quality of our workforce.

Constant improvement is the standard in our company, and as our many successfull alliances and extensive experiences have proven, Interbat will indeed continue to grow to become the partner of choice.